Real-World study reveals hidden burden of CML drug side effects
NCT ID NCT07151820
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study examined over 2,500 people with chronic myeloid leukemia (CML) to see how often side effects from their medications (tyrosine kinase inhibitors) happen and how those side effects lead to changes in treatment or extra healthcare costs. Researchers used insurance claims data to track side effects that required medical attention. The goal was to understand the real-world impact of these side effects on patients and the healthcare system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, CHRONIC MYELOID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.